Defender’s plans for motion sickness nasal gel stop with FDA rejection
The NASA and US Navy-propelled company remains confident, with Defender CEO Barry Feinberg saying a meeting with the FDA has been requested.
The NASA and US Navy-propelled company remains confident, with Defender CEO Barry Feinberg saying a meeting with the FDA has been requested.
What's Your Reaction?
